The statistic shows the distribution of the drug production value of antineoplastics in Japan in 2018, broken down by sub therapeutic category. In 2018, the production value of antimetabolites made up the largest share with approximately five percent of the total production value, followed by antitumor plant extract preparations with almost around 2.5 percent.
Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Production value of antineoplastics Japan 2015, by category
- Drug production value share of dermatologic preparations Japan 2018, by category
- Breakdown of drug production value Japan 2018, by drug form
- Production value extracorporeal diagnostic agents Japan 2016, by category
- Drug production value share of extracorporeal diagnostic age Japan 2018, by category
- Drug production value share of antibiotics Japan 2016, by category
- Drug production value of dermatologic preparations Japan 2018, by category
- Drug production value share of hormones Japan 2018, by category
- Drug production value of traditional Chinese medicines Japan 2012-2018, by category
- Drug production value blood and body fluid agents Japan 2016, by category
- Drug production value share of blood and body fluid agents Japan 2018, by category
- Sawai Pharmaceutical's total assets FY 2009-2018
- Nichi-Iko's R&D expenditure FY 2013-2020
- Japan's prescription drug market size 2008-2017
- US adults impression of the US pharma industry by age 2017
- First biosimilar marketing initiatives by MCOs in U.S. 2015
- US adults on research results impact on U.S. pharma industry by gender 2017
- Amount of cannabinoids needed to make pharmaceutical-grade compounds in 2017
- US adults' rating of impact of technology on U.S. pharma industry by gender 2017
MHLW (Japan). (August 30, 2019). Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category [Graph]. In Statista. Retrieved January 19, 2021, from https://www.statista.com/statistics/740486/drug-production-value-share-of-antineoplastics-by-category-japan/
MHLW (Japan). "Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category." Chart. August 30, 2019. Statista. Accessed January 19, 2021. https://www.statista.com/statistics/740486/drug-production-value-share-of-antineoplastics-by-category-japan/
MHLW (Japan). (2019). Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category. Statista. Statista Inc.. Accessed: January 19, 2021. https://www.statista.com/statistics/740486/drug-production-value-share-of-antineoplastics-by-category-japan/
MHLW (Japan). "Distribution of The Drug Production Value of Antineoplastics in Japan in 2018, by Sub Therapeutic Category." Statista, Statista Inc., 30 Aug 2019, https://www.statista.com/statistics/740486/drug-production-value-share-of-antineoplastics-by-category-japan/
MHLW (Japan), Distribution of the drug production value of antineoplastics in Japan in 2018, by sub therapeutic category Statista, https://www.statista.com/statistics/740486/drug-production-value-share-of-antineoplastics-by-category-japan/ (last visited January 19, 2021)